High level of primary drug resistance in Mali.

Background: As access to antiretroviral drugs increases in developing countries, it will become increasingly important to monitor the emergence of resistance and to define the molecular pathways involved to identify optimal therapeutic regimens.

Methods: We performed genotypic resistance testing on plasma obtained from 101 HIV-infected treatment-naïve individuals from Mali. Genotyping was carried out using the Virco protocols and HXB2 was used as the reference strain.

Gender-related factors influencing HIV serostatus disclosure in patients receiving HAART in West Africa.

Disclosure of HIV serostatus remains an important tool for the prevention of new infections and early initiation of treatment for HIV-positive individuals' regular sexual partners. Our aim is to identify factors associated with disclosure to partner in patients taking antiretroviral treatment, with a gender- and sex-based approach. In this study conducted in Mali and Burkina Faso, men (154) and women (164) who reported being in a marital or cohabitating relationship were included.

Inadequate adherence to antiretroviral treatment and prevention in hospital and community sites in Burkina Faso and Mali: a study by the ATARAO group.

Our objective was to determine the prevalence and identify the factors that influence antiretroviral therapy (ART) adherence among patients in Bamako and Ouagadougou. A cross-sectional study was conducted among 94 men and 176 women receiving ART. Data were collected through questionnaires and chart reviews.